These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1700348)

  • 21. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of gravidity on maternal serum markers for Down's syndrome.
    Barkai G; Goldman B; Ries L; Chaki R; Cuckle H
    Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
    Yamamoto R; Minobe S; Ebina Y; Watari H; Kudo M; Henmi F; Satomura S; Fujimoto S; Minakami H; Sakuragi N
    Congenit Anom (Kyoto); 2004 Jun; 44(2):87-92. PubMed ID: 15198721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
    Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
    Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down syndrome screening in women under 35 with maternal serum hCG.
    Suchy SF; Yeager MT
    Obstet Gynecol; 1990 Jul; 76(1):20-4. PubMed ID: 1694288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.
    Wenstrom KD; Boots LR; Cosper PC
    J Matern Fetal Med; 1996; 5(1):31-5. PubMed ID: 8796763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
    Huderer-Duric K; Skrablin S; Kuvacic I; Sonicki Z; Rubala D; Suchanek E
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):49-55. PubMed ID: 10659916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of the triple test in the detection of abnormalities of the feto-placental unit.
    Perenc M; Dudarewicz L; Kałuzewski B
    Med Sci Monit; 2000; 6(5):994-9. PubMed ID: 11208444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AFP and age screening for Down syndrome.
    Wald N; Cuckle H
    Am J Med Genet; 1988 Sep; 31(1):197-209. PubMed ID: 2464930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human chorionic gonadotrophin and trisomy 18.
    Barkai G; Chaki R; Sochat M; Goldman B
    Am J Med Genet; 1991 Oct; 41(1):52-3. PubMed ID: 1719814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
    Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
    Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
    Saller DN; Canick JA; Palomaki GE; Knight GJ; Haddow JE
    Obstet Gynecol; 1994 Nov; 84(5):852-5. PubMed ID: 7524003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prenatal diagnosis of trisomy 21].
    Massé J; Forest JC
    Ann Biol Clin (Paris); 1990; 48(8):536-40. PubMed ID: 1705107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second trimester serum markers.
    Canick JA; MacRae AR
    Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
    Hu Z; Liu X; Li L; Jia C; Li D; Liu R
    Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical screening of fetal aneuploidies and neural tube defects by "double-test" in Croatia: a 10 years' experience.
    Tislarić-Medenjak D; Kosec V; Tonković-Durisević I; Zec I; Sabolović-Rudman S; Kuna K; Herman R; Ivicević-Bakulić T; Soljacić-Vranes H; Tuckar N; Muzinić D; Butorac D; Bolanca I; Kosec A; Stipoljev F
    Coll Antropol; 2011 Sep; 35(3):957-62. PubMed ID: 22053587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is maternal serum triple screening a better predictor of Down syndrome in female than in male fetuses?
    Ghidini A; Spong CY; Grier RE; Walker CN; Pezzullo JC
    Prenat Diagn; 1998 Feb; 18(2):123-6. PubMed ID: 9516012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective evaluation of prenatal maternal serum screening for trisomy 18.
    Yankowitz J; Fulton A; Williamson R; Grant SS; Budelier WT
    Am J Obstet Gynecol; 1998 Mar; 178(3):446-50. PubMed ID: 9539506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.